Abstract
Obesity has received considerable attention in general medicine and nephrology over the last few years. This condition increases the risk of metabolic syndrome, diabetes mellitus, hypertension, and dyslipidemia, which are the main risk factors for developing chronic kidney disease (CKD). Kidney damage caused by obesity can be explained by many mechanisms, such as sympathetic nervous and renin-angiotensin-aldosterone systems activation, mechanical stress, hormonal unbalance, as well as inflammatory cytokines production. Even though creatinine-based glomerular filtration rate (GFR) equations in obese individuals have been validated (Salazar-Corcoran and CKD-MCQ), changes in body weight after bariatric surgery (BS) leads to changes in creatininemia, affecting its reliability. Thus, an average between creatine and cystatin-based GFR equations would be more appropriate in this setting. Bariatric surgery can reverse diabetes mellitus and improve hypertension, which are the main causes of CKD. Conclusion: GFR can be affected by obesity and BS, and its value should be cautiously evaluated in this setting.
Similar content being viewed by others
References
Chang AR, George J, Levey AS, Coresh J, Grams ME, Inker LA (2020) Performance of glomerular filtration rate estimating equations before and after bariatric surgery. Kidney Med 2(6):699-706.e1
KDIGO (2012) Clinical Practice Guideline for the Evaluation andManagement of Chronic Kidney Disease. Kidney Int Suppl 3(1):1–163
Li K, Zou J, Ye Z, Di J, Han X, Zhang H et al (2016) Effects of bariatric surgery on renal function in obese patients: a systematic review and meta analysis. PLoS ONE 11(10):e0163907
Billeter AT, Kopf S, Zeier M, Scheurlen K, Fischer L, Schulte TM et al (2016) Renal function in Type 2 diabetes following gastric bypass. Dtsch Arzteblatt Int 113(49):827–833
Provenzano M, Jongs N, Vart P, Stefánsson B, Chertow G, Langkilde AM, McMurray J, Correa-Rotter R, Rossing P, Sjöström D, Toto R, Wheeler D, Heerspink H, DAPA-CKD Trial Committees and Investigators (2022) The kidney protective effects of the sodium-glucose cotransporter-2 inhibitor dapagliflozin, are present in patients with CKD treated with mineralocorticoid receptor antagonists. Kidney Int Rep 7(3):436–443. https://doi.org/10.1016/j.ekir.2021.12.013
Ramspek C, Evans M, Wanner C, Drechsler C, Chesnaye N, Szymczak M, Krajewska M, Torino C, Porto G, Hayward S, Caskey F, Dekker F, Jager K, van Diepen M, EQUAL Study Investigators (2021) Kidney failure prediction models: a comprehensive external validation study in patients with advanced CKD. J Am Soc Nephrol 32(5):1174–1186. https://doi.org/10.1681/ASN.2020071077
Comai G, Corradetti V, Bini C, Tondolo F, Hu L, Valente S, Pasquinelli G, Malvi D, Vasuri F, Ravaioli M, Provenzano M, La Manna G (2023) Histological findings of diabetic kidneys transplanted in non-diabetic recipients: a case series. Int Urol Nephrol. https://doi.org/10.1007/s11255-023-03552-x
García-Carro C, Vergara A, Bermejo S, Azancot MA, Sellarés J, Soler MJ (2021) A Nephrologist perspective on obesity: from kidney injury to clinical management. Front Med 8:1–11. https://doi.org/10.3389/fmed.2021.655871
Silva da Junior GB, Bentes ACSN, Daher EDF, de Matos SMA (2017) Obesity and kidney disease. J Bras Nefrol Orgao Of Soc Bras E Lat-Am Nefrol 39(1):65–69
Sharma I, Liao Y, Zheng X, Ys K (2021) New pandemic: obesity and associated nephropathy. Front Med. https://doi.org/10.3389/fmed.2021.673556
Chagnac A, Zingerman B, Rozen-Zvi B, Herman-Edelstein M (2019) Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity. Nephron 143(1):38–42. https://doi.org/10.1159/000499486
Tsuboi N, Okabayashi Y, Shimizu A, Yokoo T (2017) The renal pathology of obesity. Kidney Int Rep 2(2):251–260. https://doi.org/10.1016/j.ekir.2017.01.007
Aiello F, Dueñas EP, Musso CG (2017) Senescent nephropathy: the new renal síndrome. Healthcare (Basel). https://doi.org/10.3390/healthcare5040081
Chuah LL, Miras AD, Perry LM, Frankel AH, Towey DJ, Al-Mayahi Z et al (2018) Measurement of glomerular filtration rate in patients undergoing obesity surgery. BMC Nephrol 19(1):383
D’Agati VD, Chagnac A, de Vries APJ, Levi M, Porrini E, Herman-Edelstein M et al (2016) Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol 12(8):453–471
von Scholten BJ, Persson F, Svane MS, Hansen TW, Madsbad S, Rossing P (2017) Effect of large weight reductions on measured and estimated kidney function. BMC Nephrol 18(1):52
Kittiskulnam P, Tiskajornsiri K, Katavetin P, Chaiwatanarat T, Eiam-Ong S, Praditpornsilpa K (2020) The failure of glomerular filtration rate estimating equations among obese population. PLoS ONE 15(11):1–13
Musso CG, González-Torres H (2019) How to evaluate glomerular filtration rate in the obese patient. Rev Colomb Nefrol. 6(2):84–86
Koch V (2021) Obesity facts and their influence on renal function across the life span. Front Med 8:1–10. https://doi.org/10.3389/fmed.2021.704409
Rothberg AE, McEwen LN, Herman WH (2020) Severe obesity and the impact of medical weight loss on estimated glomerular filtration rate. PLoS ONE 15(2):e0228984
Musso CG, Álvarez-Gregori J, Jauregui J, Macías-Núñez JF (2016) Glomerular filtration rate equations: a comprehensive review. Int Urol Nephrol 48:1105–1110
Delanaye P, Cavalier E, Pottel H, Stehlé T (2023) New and old GFR equations: a European perspective. Clin Kidney J 16(9):1375–1383. https://doi.org/10.1093/ckj/sfad039
Nawaz S, Chinnadurai R, Al-Chalabi S, Evans P, Kalra PA, Syed AA, Sinha S (2023) Obesity and chronic kidney disease: a current review. Obes Sci Pract 9:61–74
Grangeon-Chapon C, Laurain A, Esnault VLM, Cruzel C, Iannelli A, Favre GA (2021) Extracellular fluid volume: a suitable indexation variable to assess impact of bariatric surgery on glomerular filtration rate in patients with chronic kidney disease. PLoS ONE 16(8):e0256234
GalleT M, Drouet C, Berriolo-Riedinger A, Nicolas A, Cochet A, Riedinger JM (2021) Effect of obesity, age and gender on glomerular filtration rate measured in normal adults. Ann Biol Clin (Paris). https://doi.org/10.1684/abc.2021.1615
Erstad BL (2021) Nix DE Assessment of kidney function in patients with extreme obesity: a narrative review. Ann Pharmacother 55(1):80–88
López-Martínez M, Luis-Lima S, Morales E, Navarro-Díaz M, Negrín-Mena N, Folgueras T, Escamilla B, Estupiñán S, Delgado-Mallén P, Marrero-Miranda D, González-Rinne A, Miquel-Rodríguez RM, Cobo-Caso MA, Díaz-Martín L, Jiménez-Sosa A, González-Rinne F, Torres A, Porrini E (2020) The estimation of GFR and the adjustment for BSA in overweight and obesity: a dreadful combination of two errors. Int J Obes 44(5):1129–1140
Capotondo MM, Aroca-Martinez G, Specterman SR, Musso CG (2023) Acute kidney injury in oncology. Interdisciplanary Cancer Research. Springer, Cham
Friedman AN, Moe S, Fadel WF, Inman M, Mattar SG, Shihabi Z et al (2014) Predicting the glomerular filtration rate in bariatric surgery patients. Am J Nephrol 39(1):8–15
Rosenstock JL, Pommier M, Stoffels G, Patel S, Michelis MF (2018) Prevalence of proteinuria and albuminuria in an obese population and associated risk factors. Front Med 5:122
Gheith O, Al-Otaibi T, Halim MA, Mahmoud T, Mosaad A, Yagan J et al (2017) Bariatric surgery in renal transplant patients. Exp Clin Transplant Off J Middle East Soc Organ Transplant 15(Suppl 1):164–169
Chang AR, Grams ME, Navaneethan SD (2017) Bariatric surgery and kidney-related outcomes. Kidney Int Rep 2(2):261–270
Ritz E (2013) Bariatric surgery and the kidney—much benefit, but also potential harm. Clin Kidney J 6(4):368–372
Pommer W (2018) Preventive nephrology: the role of obesity in different stages of chronic kidney disease. Kidney Dis Basel Switz 4(4):199–204
Dias RSC, Calado IL, de Alencar JD, Hortegal EV, Santos EJF, de Brito DJ, A, et al (2018) Abdominal obesity and reduction of glomerular filtration. Rev Assoc Medica Bras 1992 64(4):346–353
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Schwartz, P., Capotondo, M.M., Quaintenne, M. et al. Obesity and glomerular filtration rate. Int Urol Nephrol 56, 1663–1668 (2024). https://doi.org/10.1007/s11255-023-03862-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-023-03862-0